What is the approximate medical insurance reimbursement rate for Bedaquiline and how to apply?

Bedaquiline (Bedaquiline) is an innovative first-line anti-tuberculosis drug for multi-drug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) in recent years. It has attracted great attention after its introduction into the domestic market. Bedaquiline fumarate tablets have been launched in China and have been included in the Class B medical insurance drug list, mainly providing reimbursement support for patients with multi-drug-resistant tuberculosis. This means that eligible patients can enjoy partial coverage of medical insurance funds during the treatment process, significantly reducing the burden of medication.

Medical insurance reimbursement ratios vary depending on regions and medical insurance policies. In most provinces and cities, the reimbursement ratio for Class B medical insurance drugs is usually around 70%. The specific reimbursement amount also depends on the total amount of local medical insurance and outpatient or inpatient usage. For inpatients, bedaquiline is more likely to receive a high proportion of reimbursement support in the hospital inpatient reimbursement system, while outpatient drug purchases may be limited by annual reimbursement limits. The application process usually involves hospital doctors issuing prescriptions, filling out medical insurance approval forms, and submitting patient medical records and evidence of drug-resistant tuberculosis diagnosis. Some areas also require review by municipal or provincial tuberculosis prevention and control centers to ensure that drugs are used rationally and meet medical insurance conditions.

In addition, if the patient is covered by the medical insurance policy, the pharmacy or hospital will directly calculate the reimbursement amount according to the medical insurance system, without the patient having to bear the full cost. However, for cross-regional medical treatment or drug purchase from non-designated hospitals, you may need to apply for off-site registration or reimbursement pre-examination in advance to ensure that you can eventually receive reimbursement according to the prescribed proportion. Generally speaking, the establishment of the bedaquiline medical insurance policy reflects the country's emphasis on the treatment of multidrug-resistant tuberculosis, and it also allows patients to gain greater accessibility to high-cost innovative drugs.

Reference materials:https://en.wikipedia.org/wiki/Bedaquiline